BMC Pharmacology and Toxicology

SJR Rank #7,527H-index: 52SJR: 0.752Best quartile: Q2Open AccessAPC: US$3,090Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

BioMed Central Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Medicine (miscellaneous)Q2
  • PharmacologyQ2
  • Pharmacology (medical)Q2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Pharmacovigilance and Adverse Drug ReactionsNitric Oxide and Endothelin EffectsDrug-Induced Hepatotoxicity and ProtectionPhosphodiesterase function and regulationReceptor Mechanisms and SignalingPharmaceutical Practices and Patient OutcomesDiabetes Treatment and ManagementPoisoning and overdose treatmentsChemotherapy-induced organ toxicity mitigationPharmacogenetics and Drug Metabolism

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs070140210280

Documents per Year

20222025055110165220

Detailed Information

ISSN

2050-6511

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

3.63

References per Document

47.15

Coverage

2012-2026

Scope

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.

Metrics from SCImago Journal Rank 2025. View on SCImago